EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion

Sang Jun Han iD, Prashi Jain, Yosef Gilad iD, Yan Xia, Nuri Sung, Mi Jin Park, Adam M Dean, Rainer B Lanz iD, Jianming Xu iD, Clifford C Dacso iD, David M Lonard iD, Bert W O'Malley iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2221707120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Sang Jun Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cellular Biology, Baylor College of Medicine, Houston, TX 77030. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammary Neoplasms, Animal, Nuclear Receptor Coactivator 3. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Steroid receptor coactivator 3 (SRC-3) is most strongly expressed in regulatory T cells (Tregs) and B cells, suggesting that it plays an important role in the regulation of Treg function. Using an aggressive E0771 mouse breast cell line syngeneic immune-intact murine model, we observed that breast tumors were “permanently eradicated” in a genetically engineered tamoxifen-inducible Treg-cell-specific SRC-3 knockout (KO) female mouse that does not possess a systemic autoimmune pathological phenotype. A similar eradication of tumor was noted in a syngeneic model of prostate cancer. A subsequent injection of additional E0771 cancer cells into these mice showed continued resistance to tumor development without the need for tamoxifen induction to produce additional SRC-3 KO Tregs. SRC-3 KO Tregs were highly proliferative and preferentially infiltrated into breast tumors by activating the chemokine (C-C motif) ligand (Ccl) 19/Ccl21/chemokine (C-C motif) receptor (Ccr)7 signaling axis, generating antitumor immunity by enhancing the interferon-γ/C-X-C motif chemokine ligand (Cxcl) 9 signaling axis to facilitate the entrance and function of effector T cells and natural killer cells. SRC-3 KO Tregs also show a dominant effect by blocking the immune suppressive function of WT Tregs. Importantly, a single adoptive transfer of SRC-3 KO Tregs into wild-type E0771 tumor-bearing mice can completely abolish preestablished breast tumors by generating potent antitumor immunity with a durable effect that prevents tumor reoccurrence. Therefore, treatment with SRC-3-deleted Tregs represents an approach to completely block tumor growth and recurrence without the autoimmune side effects that typically accompany immune checkpoint modulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMammary Neoplasms, AnimalNuclear Receptor Coactivator 3AnimalsFemaleMaleMiceLigandsMice, KnockoutT-Lymphocytes, RegulatoryTamoxifen

Stichwörter der Autor:innen

adoptive cell transferinterferon-γregulatory T cellssteroid receptor coactivator 3syngeneic murine model of breast cancer

Substanzen

LigandsNuclear Receptor Coactivator 3Tamoxifen

Autor:innen und Institutionen

  • Department of Molecular Cellular Biology, Baylor College of Medicine, Houston, TX 77030.
  • Nuclear Receptor, Transcription and Chromatin Biology Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030.
  • Department of Medicine, Baylor College of Medicine, Houston, TX 77030.

ORCID-Profile: Sang Jun Han, Yosef Gilad, Rainer B Lanz, Jianming Xu, Clifford C Dacso, David M Lonard, Bert W O'Malley

Förderung

  • NICHD NIH HHS
  • HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Han, S. J., Jain, P., Gilad, Y., Xia, Y., Sung, N., Park, M. J., Dean, A. M., Lanz, R. B., Xu, J., Dacso, C. C., Lonard, D. M., & O'Malley, B. W. (2023). Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2221707120

Vancouver

Han SJ, Jain P, Gilad Y, Xia Y, Sung N, Park MJ, et al. Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2221707120

BibTeX
@article{Han2023,
  author = {Han, Sang Jun and Jain, Prashi and Gilad, Yosef and Xia, Yan and Sung, Nuri and Park, Mi Jin and Dean, Adam M and Lanz, Rainer B and Xu, Jianming and Dacso, Clifford C and Lonard, David M and O'Malley, Bert W},
  title = {Steroid receptor coactivator 3 is a key modulator of regulatory T cell–mediated tumor evasion},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2221707120}
}
Kostenlos starten →